Literature DB >> 27131890

Real-time kinetic method to monitor isopeptidase activity of transglutaminase 2 on protein substrate.

Kiruphagaran Thangaraju1, Beáta Biri2, Gitta Schlosser3, Bence Kiss2, László Nyitray2, László Fésüs4, Róbert Király5.   

Abstract

Transglutaminase 2 (TG2) is a ubiquitously expressed multifunctional protein with Ca(2+)-dependent transamidase activity forming protease-resistant N(ε)-(γ-glutamyl) lysine crosslinks between proteins. It can also function as an isopeptidase cleaving the previously formed crosslinks. The biological significance of this activity has not been revealed yet, mainly because of the lack of a protein-based method for its characterization. Here we report the development of a novel kinetic method for measuring isopeptidase activity of human TG2 by monitoring decrease in the fluorescence polarization of a protein substrate previously formed by crosslinking fluorescently labeled glutamine donor FLpepT26 to S100A4 at a specific lysine residue. The developed method could be applied to test mutant enzymes and compounds that influence isopeptidase activity of TG2.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fluorescence anisotropy; Isopeptidase activity; S100A4; Transglutaminase 2

Mesh:

Substances:

Year:  2016        PMID: 27131890     DOI: 10.1016/j.ab.2016.04.012

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

1.  Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell Lysates.

Authors:  Sandra Hauser; Paul Sommerfeld; Johanna Wodtke; Christoph Hauser; Paul Schlitterlau; Jens Pietzsch; Reik Löser; Markus Pietsch; Robert Wodtke
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

2.  Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2.

Authors:  Kiruphagaran Thangaraju; Róbert Király; Máté A Demény; János András Mótyán; Mónika Fuxreiter; László Fésüs
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.